THALIDOMIDE 50mg Capsule: Precision Immunomodulation for Multiple Myeloma and Erythema Nodosum Leprosum (ENL) Are you searching for a reliable THALIDOMIDE 50mg Capsule exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of highly regulated immunomodulatory drugs (IMiDs). We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology and leprostatic medications reach institutional pharmacies with 100% pharmaceutical integrity and compliance. Detailed Product Profile: What is THALIDOMIDE 50mg? THALIDOMIDE 50mg is an oral therapeutic agent containing the active ingredient Thalidomide. Originally known for its sedative properties, it has been repurposed as a powerful antineoplastic and anti-inflammatory medication. Manufactured under stringent quality standards, this 50mg capsule is primarily utilized in oncology to disrupt cancer cell growth and in infectious disease to manage severe inflammatory complications of Hansen's disease (leprosy). 1. Therapeutic Indications Multiple Myeloma (MM): Used in combination with dexamethasone for the treatment of newly diagnosed multiple myeloma. It is a cornerstone of “triplet“ and “quadruplet“ therapy regimens. Erythema Nodosum Leprosum (ENL): Indicated for the acute treatment of the cutaneous manifestations of moderate to severe ENL and as maintenance therapy to prevent recurrence. Off-Label Oncology Uses: Occasionally utilized in specialized protocols for refractory cancers, including certain brain tumors and Kaposi's sarcoma, under strict medical supervision. 2. Mechanism of Action: The “Cereblon“ Pathway Cereblon Binding: It binds to Cereblon (CRBN), part of an E3 ubiquitin ligase complex. This binding triggers the selective degradation of specific transcription factors (Aiolos and Ikaros), which are essential for the survival of B-cells and myeloma cells. Anti-Angiogenesis: It prevents the formation of new blood vessels (angiogenesis) that tumors require to grow, effectively “starving“ the malignant mass. Cytokine Modulation: It inhibits the production of Tumor Necrosis Factor-alpha (TNF-α) and other pro-inflammatory cytokines, which is the primary reason for its efficacy in treating ENL. Immune Enhancement: It stimulates T-cells and Natural Killer (NK) cells to better recognize and attack cancerous cells 3. Administration and Dosing Management Standard Dosing: The typical oncology starting dose is 200mg once daily (four 50mg capsules), though 50mg is often used for dose titration and maintenance. Timing: Should be taken once daily at bedtime, at least 1 hour after the evening meal, to minimize the impact of its sedative effects. Safety Handling: Capsules must be swallowed whole. Healthcare providers and caregivers should handle capsules with care; if a capsule is broken, avoid contact with skin or inhalation of the powder. Clinical Side Effects & Safety Monitoring Embryo-Fetal Toxicity (Teratogenicity): This is the most critical risk. Thalidomide causes severe birth defects. Use is strictly governed by REMS/S.T.E.P.S. programs globally. Peripheral Neuropathy: Monitoring for tingling, numbness, or pain in the hands and feet. This can be permanent if not caught early. Venous Thromboembolism (VTE): Increased risk of DVT and pulmonary embolism, especially when combined with steroids. Thromboprophylaxis (aspirin or anticoagulants) is often prescribed. Somnolence and Fatigue: Due to its sedative nature, patients should avoid driving or operating heavy machinery. Bradycardia: Monitoring of heart rate is advised, especially in patients with pre-existing cardiac conditions. Why Source THALIDOMIDE 50mg from Ernest Oncology? Verified Authenticity: Direct sourcing of high-integrity Thalidomide with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex export regulations and specialized shipping requirements for the USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us